Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06062186 · ClinicalTrials.gov registry record · NA

Acute Effects of Naturally Occurring Tea and Coffee-based Ingredients on Cognitive Performance

A NA study of Cognitive Change, sponsored by The Center for Applied Health Sciences.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06062186 is a NA study of Cognitive Change that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 40 participants, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06062186, a NA study of Cognitive Change, has completed, sponsored by The Center for Applied Health Sciences.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses including mental clarity, mood, focus, concentration, productivity, anxiety/stress, happiness, and accuracy.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT AmaTea Guayusa Extract
  • DIETARY_SUPPLEMENT Lion's Mane

Study Locations (1)

Ohio

  • The Center for Applied Health Sciences - Canfield

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-04-05
Est. Completion 2023-09-15
Phase NA

What the Registry Record Tells You About NCT06062186

The ClinicalTrials.gov registry entry for NCT06062186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 44 other Cognitive Change trials with a reported enrollment target (78% lower). The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cognitive Change appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06062186 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06062186 about?

NCT06062186 is a clinical study titled "Acute Effects of Naturally Occurring Tea and Coffee-based Ingredients on Cognitive Performance". This study is a double-blind, randomized, three-arm, single-dose, placebo-controlled crossover trial of forty (40) apparently healthy male and female participants. The objective of this study is to assess the effects of AmaTea Max Organic Guayusa Extract and Lion's Mane on cognitive responses includ...

What is the current status of trial NCT06062186?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-04-05. Estimated completion is 2023-09-15.

What conditions does trial NCT06062186 study?

This clinical trial studies the following conditions: Cognitive Change.

What interventions are being tested in trial NCT06062186?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AmaTea Guayusa Extract (DIETARY_SUPPLEMENT), Lion's Mane (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06062186?

This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06062186 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Change

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.